Valuation: Illumina, Inc.

Market Cap 28.78B 25.17B 23.22B 21.44B 40.69B 2,745B 41.37B 277B 109B 1,352B 108B 106B 4,648B P/E 2026 *
40.6x
P/E 2027 * 33.5x
Enterprise Value 29.3B 25.63B 23.64B 21.83B 41.43B 2,794B 42.12B 282B 111B 1,377B 110B 108B 4,732B EV / Sales 2026 *
6.41x
EV / Sales 2027 * 5.93x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.84%
1 week+0.81%
Current month+8.17%
1 month+17.07%
3 months+57.28%
6 months+34.83%
Current year+45.01%
1 week 184.66
Extreme 184.66
196.66
1 month 157.63
Extreme 157.63
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
06-30
Corvex Management LP
OtherCompany 0 0%
06-30Free

Director

142 0.0001%
06-30Free

Director

167 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%+0.81%+90.10%+3.40% 28.78B
+0.45%+0.69%+22.36%+1.97% 196B
-1.16%-4.51%-22.67%+19.55% 144B
+1.57%+0.57%-3.14%-15.11% 141B
-0.49%-0.82%-56.89%-15.05% 66.54B
+0.96%-2.29%+17.02%+0.62% 53.09B
+0.61%-1.09%-27.71%-30.42% 44.12B
+0.52%+2.75%+8.15%+13.46% 37.93B
-0.19%-0.75%+6.55%+42.23% 36.96B
-2.20%-2.75%-21.00%-5.88% 29.41B
Average +0.23%-0.63%+1.28%+1.48% 77.76B
Weighted average by Cap. +0.64%-0.88%-1.17%+0.98%

Financials

2026 *2027 *
Net sales 4.57B 4B 3.69B 3.41B 6.46B 436B 6.57B 44.06B 17.3B 215B 17.16B 16.79B 738B 4.83B 4.22B 3.89B 3.6B 6.82B 460B 6.94B 46.53B 18.27B 227B 18.12B 17.73B 780B
Net income 723M 633M 584M 539M 1.02B 69B 1.04B 6.97B 2.74B 33.99B 2.72B 2.66B 117B 869M 760M 701M 647M 1.23B 82.87B 1.25B 8.38B 3.29B 40.82B 3.26B 3.19B 140B
Net Debt 522M 457M 421M 389M 738M 49.78B 750M 5.03B 1.98B 24.52B 1.96B 1.92B 84.31B -160M -140M -129M -119M -226M -15.24B -230M -1.54B -605M -7.51B -600M -587M -25.8B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
10/07/26 $190.20 -1.84% 1,076,328
09/07/26 $193.76 +3.17% 1,725,053
08/07/26 $187.81 -2.06% 2,650,616
07/07/26 $191.76 -1.32% 2,582,918
06/07/26 $194.33 +2.99% 2,103,315
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
190.20USD
Average target price
155.63USD
Spread / Average Target
-18.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock